会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • Imaging of drug accumulation as a guide to antitumor therapy
    • 成像药物积累作为抗肿瘤治疗的指南
    • US07141234B1
    • 2006-11-28
    • US10088561
    • 2000-09-21
    • Jerry M. CollinsRaymond W. KleckerLawrence Anderson
    • Jerry M. CollinsRaymond W. KleckerLawrence Anderson
    • A61K49/00
    • A61K51/0491A61K51/0417A61K51/0421A61K51/0455
    • The present invention describes the use of radio-labeled antitumor drugs in the treatment of solid tumors by the method of administering a radio-labelled anticancer drug to a patient and imaging at least a part of the patient using Positron Emission Tomography imaging. The method is used to monitor delivery of antitumor drugs to tumors and may be used to predict the effectiveness of therapy with a particular antitumor drug or combination of antitumor drugs, to assess the effectiveness of modulators of cellular accumulation, to individualize therapy and to evaluate the effectiveness of antitumor drugs with respect to particular cancers. Particularly preferred drugs are labeled taxanes, e.g., 11C-paclitaxel and 11C-docetaxel, labeled anthracyclines, e.g., 11C-doxorubicin and 11C-epirubicin, and other radio-labeled drug, e.g. 11C-topotecan and 11C-mitoxantrone. The invention further describes antitumor drugs labeled with the radioactive label 11C and methods of preparing radio-labeled drugs.
    • 本发明描述了通过向患者施用放射性标记的抗癌药物并使用正电子发射断层扫描成像对至少一部分患者进行成像的方法来使用放射性标记的抗肿瘤药物来治疗实体瘤。 该方法用于监测抗肿瘤药物对肿瘤的递送,并且可用于预测用特定抗肿瘤药物或抗肿瘤药物组合治疗的有效性,以评估细胞积聚调节剂的有效性,个体化治疗和评价 抗肿瘤药物对特定癌症的有效性。 特别优选的药物是标记的紫杉烷类,例如,11 C-紫杉醇和11 C-多西他赛,标记的蒽环类药物,例如,11-多柔比星和 C-表柔比星和其他放射性标记的药物,例如, C-托泊替康和11-西米托蒽醌。 本发明还描述了用放射性标记物11C标记的抗肿瘤药物和制备放射性标记药物的方法。